Dispatches from Korea

Inside Celltrion: a biosimilar success story built on landfill

By Dan Stanton

29-Aug-2016 - Last updated on 30-Aug-2016 at 12:56 GMT

Biopharma-Reporter visited the 'pioneers of the mAb biosimilar industry'

Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, Korea.

Biopharma-Reporter visited the 'pioneers of the mAb biosimilar industry'

Related news

Related products

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...

Guide to cell harvesting using Pall technology

Pall Life Sciences | 20-Feb-2018 | Technical / White Paper

Accelerate Your Process Development. Your technology selection guide for the clarification of mAb processes.

Inline diafiltration enables continuous processing

Pall Life Sciences | 13-Feb-2018 | Application Note

The Cadence inline diafiltration (ILDF) device is designed for continuous processing, in-process buffer exchange or contaminant removal in various processes...

Discover Fast and Simple Water Intrusion Testing

Pall Life Sciences | 13-Nov-2017 | Application Note

At Pall we have supported the water intrusion test for more than 20 years and we developed the Palltronic® AquaWIT IV system to deliver fast and simple...